Recent advances of SHP2 inhibitors in cancer therapy: current development and clinical application

X Yuan, H Bu, J Zhou, CY Yang… - Journal of medicinal …, 2020 - ACS Publications
SHP2 (Src homology-2 domain-containing protein tyrosine phosphatase-2) is a non-
receptor protein tyrosine phosphatase that removes tyrosine phosphorylation. Functionally …

Protein tyrosine phosphatases–from housekeeping enzymes to master regulators of signal transduction

NK Tonks - The FEBS journal, 2013 - Wiley Online Library
There are many misconceptions surrounding the roles of protein phosphatases in the
regulation of signal transduction, perhaps the most damaging of which is the erroneous view …

Quantitative evidence for early metastatic seeding in colorectal cancer

Z Hu, J Ding, Z Ma, R Sun, JA Seoane, J Scott Shaffer… - Nature …, 2019 - nature.com
Both the timing and molecular determinants of metastasis are unknown, hindering treatment
and prevention efforts. Here we characterize the evolutionary dynamics of this lethal process …

Protein tyrosine phosphatases as potential therapeutic targets

R He, Z Yu, R Zhang, Z Zhang - Acta pharmacologica sinica, 2014 - nature.com
Protein tyrosine phosphorylation is a key regulatory process in virtually all aspects of cellular
functions. Dysregulation of protein tyrosine phosphorylation is a major cause of human …

Exploiting the PI3K/AKT pathway for cancer drug discovery

BT Hennessy, DL Smith, PT Ram, Y Lu… - Nature reviews Drug …, 2005 - nature.com
Evolving studies with several different targeted therapeutic agents are demonstrating that
patients with genomic alterations of the target, including amplification, translocation and …

The epithelial–mesenchymal transition: new insights in signaling, development, and disease

JM Lee, S Dedhar, R Kalluri… - The Journal of cell biology, 2006 - rupress.org
The conversion of an epithelial cell to a mesenchymal cell is critical to metazoan
embryogenesis and a defining structural feature of organ development. Current interest in …

Cancer epigenomics: beyond genomics

J Sandoval, M Esteller - Current opinion in genetics & development, 2012 - Elsevier
For many years cancer research has focused on genetic defects, but during the last decade
epigenetic deregulation has been increasingly recognized as a hallmark of cancer. The …

Protein tyrosine phosphatases: from genes, to function, to disease

NK Tonks - Nature reviews Molecular cell biology, 2006 - nature.com
The protein tyrosine phosphatase (PTP) superfamily of enzymes functions in a coordinated
manner with protein tyrosine kinases to control signalling pathways that underlie a broad …

The Hippo pathway in intestinal regeneration and disease

AW Hong, Z Meng, KL Guan - Nature reviews Gastroenterology & …, 2016 - nature.com
The Hippo pathway is a signalling cascade conserved from Drosophila melanogaster to
mammals. The mammalian core kinase components comprise MST1 and MST2, SAV1 …

[HTML][HTML] Proteogenomic analysis reveals exosomes are more oncogenic than ectosomes

S Keerthikumar, L Gangoda, M Liem, P Fonseka… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Extracellular vesicles (EVs) include the exosomes (30-100 nm) that are produced through
the endocytic pathway via the multivesicular bodies and the ectosomes (100-1000 nm) that …